Ozurdex
Payments companies reported to CMS as associated with Ozurdex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ozurdex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ozurdex
These are the largest totals companies reported as associated with Ozurdex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Seenu Hariprasad | Chicago, IL | Ophthalmology | $53,664.13 |
| Daniel Kiernan | Sarasota, FL | Ophthalmology | $52,561.66 |
| Christina Weng | Houston, TX | Ophthalmology | $52,366.33 |
| Mark Dacey | Denver, CO | Ophthalmology | $44,937.10 |
| Brian DO | Chevy Chase, MD | Retina Specialist | $37,961.98 |
| Lejla Vajzovic | Durham, NC | Ophthalmology | $36,744.75 |
| Ajay Singh | Independence, MO | Ophthalmology | $35,237.45 |
| Rishi Singh | Boston, MA | Ophthalmology | $34,734.57 |
| Michael Singer | San Antonio, TX | Ophthalmology | $33,569.20 |
| Ayham Skaf | Chula Vista, CA | Retina Specialist | $32,909.67 |
Prescribed Ozurdex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.